↓ Skip to main content

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells

Overview of attention for article published in Frontiers in immunology, March 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
5 X users
patent
6 patents
wikipedia
1 Wikipedia page
video
1 YouTube creator

Citations

dimensions_citation
328 Dimensions

Readers on

mendeley
484 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
Published in
Frontiers in immunology, March 2016
DOI 10.3389/fimmu.2016.00091
Pubmed ID
Authors

Hans Klingemann, Laurent Boissel, Frances Toneguzzo

Abstract

Natural killer (NK) cells are potent cytotoxic effector cells for cancer therapy and potentially for severe viral infections. However, there are technical challenges to obtain sufficient numbers of functionally active NK cells from a patient's blood since they represent only 10% of the lymphocytes and are often dysfunctional. The alternative is to obtain cells from a healthy donor, which requires depletion of the allogeneic T cells to prevent graft-versus-host reactions. Cytotoxic cell lines have been established from patients with clonal NK-cell lymphoma. Those cells can be expanded in culture in the presence of IL-2. Except for the NK-92 cell line, though, none of the other six known NK cell lines has consistently and reproducibly shown high antitumor cytotoxicity. Only NK-92 cells can easily be genetically manipulated to recognize specific tumor antigens or to augment monoclonal antibody activity through antibody-dependent cellular cytotoxicity. NK-92 is also the only cell line product that has been infused into patients with advanced cancer with clinical benefit and minimal side effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 484 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Turkey 1 <1%
Taiwan 1 <1%
Unknown 482 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 92 19%
Researcher 84 17%
Student > Master 59 12%
Student > Bachelor 56 12%
Other 28 6%
Other 52 11%
Unknown 113 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 121 25%
Immunology and Microbiology 74 15%
Agricultural and Biological Sciences 68 14%
Medicine and Dentistry 40 8%
Pharmacology, Toxicology and Pharmaceutical Science 16 3%
Other 40 8%
Unknown 125 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2023.
All research outputs
#1,426,484
of 25,394,764 outputs
Outputs from Frontiers in immunology
#1,237
of 31,554 outputs
Outputs of similar age
#23,745
of 314,628 outputs
Outputs of similar age from Frontiers in immunology
#6
of 146 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,554 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,628 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 146 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.